Reprogramming of Glioblastoma-Immune Crosstalk to Overcome Immunotherapy Failure 2258791

作者
Shuozhi Liu,Lizmarie Garcia-Rivera,Michael A. LaPorta,Varsha Mathew,Edward So,Raghavendra Vadla,Frank B. Furnari,Susan M. Kaech
出处
期刊:Journal of Immunology [American Association of Immunologists]
卷期号:215 (Supplement_1)
标识
DOI:10.1093/jimmun/vkag141.626
摘要

Abstract Introduction Glioblastoma multiforme (GBM) is a lethal brain cancer with a median survival of less than a year. Immunotherapies, such as immune checkpoint blockade (ICB), represent promising treatment options but still face challenges due to tumor resilience. Understanding how the brain and tumor environment shape immune responses is critical to overcoming therapy failure. GBM tumors are heterogeneous, with four subtypes: mesenchymal-like (MES), astrocyte-like (AC), oligodendrocyte-progenitor-like (OPC), and neural-progenitor-like (NPC), but their interactions with immune cells remain unclear. Here, this study aims to identify targetable GBM subtype-immune interactions that undermine ICB efficacy. Methods We applied Xenium spatial single-cell transcriptomics in an orthotopic GBM mouse model to achieve high-resolution mapping of spatial relationships between tumor and immune cell populations. We further employed small-molecule inhibitors to suppress mesenchymal (MES) subtypes and evaluate their synergistic efficacy with anti—PD-1 immunotherapy in vivo. Results Spatial transcriptomic profiling demonstrated that tumoricidal T cells and immunosuppressive tumor-associated macrophages (TAMs) were concentrated within mesenchymal-like (MES) GBM regions. Ligand—receptor mapping revealed that MES-like tumor cells and TAMs overexpress extracellular matrix proteins such as fibronectin (Fn1), which may hinder T-cell function. As the bromodomain-containing protein 2 (BRD2) complex drives the MES-like phenotype, its inhibition decreased Fn1 expression in GBM cells and, when combined with anti—PD-1 therapy, markedly prolonged survival in mice compared to anti—PD-1 treatment alone. Conclusion This study identifies a targetable molecular axis linking the BRD2 complex to fibronectin-driven immune suppression in mesenchymal-like GBM niches. By disrupting this pathway, BRD2 inhibition enhances the efficacy of immune checkpoint blockade, offering a promising combinatorial therapeutic strategy. Funding Source National Institute of Health Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wanci的应助被微笑念寒采纳,获得10
刚刚
丸子发布了新的文献求助10
刚刚
慕青的应助被微光采纳,获得10
刚刚
Code_king发布了新的文献求助10
1秒前
汉堡宝发布了新的文献求助10
1秒前
Code_king发布了新的文献求助10
1秒前
YOLO发布了新的文献求助10
1秒前
Juvenilesy的应助被江水ppt大王采纳,获得10
1秒前
彭于晏的应助被忧伤的初露采纳,获得10
1秒前
1秒前
zyy发布了新的文献求助10
1秒前
彭于彦祖的应助被结实的灵阳采纳,获得30
1秒前
1秒前
Newmem完成签到,获得积分10
1秒前
Code_king发布了新的文献求助10
2秒前
涨涨发布了新的文献求助10
2秒前
tyche发布了新的文献求助10
2秒前
无极微光的应助被从容的绿蝶采纳,获得20
2秒前
犹豫寄真完成签到,获得积分20
3秒前
NexusExplorer的应助被Dy_1941采纳,获得10
3秒前
yue完成签到 ,获得积分20
3秒前
家里有可爱多完成签到 ,获得积分10
3秒前
3秒前
科研玉兔完成签到,获得积分10
3秒前
曦和完成签到,获得积分10
3秒前
4秒前
4秒前
orixero的应助被呀学习采纳,获得10
4秒前
4秒前
Code_king发布了新的文献求助10
4秒前
ww发布了新的文献求助50
5秒前
yeandpeng完成签到,获得积分10
5秒前
wave关注了科研通微信公众号
5秒前
Code_king发布了新的文献求助10
5秒前
5秒前
元气饱满完成签到,获得积分10
5秒前
嘟嘟嘟发布了新的文献求助20
5秒前
Code_king发布了新的文献求助10
5秒前
6秒前
乐乐的应助被来一杯忌廉采纳,获得30
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8176287
求助须知:如何正确求助?哪些是违规求助? 9567719
关于积分的说明 21794359
捐赠科研通 7771008
什么是DOI,文献DOI怎么找? 3431998
关于科研通互助平台的介绍 2556315
邀请新用户注册赠送积分活动 2477650